This inventor holds 1 USPTO granted patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David M Valenzuela: Innovator in Genetic Modification
Introduction
David M Valenzuela is a notable inventor recognized for his contributions to the field of genetic modification. He has developed innovative methods that enhance the precision of genetic alterations, which can have significant implications in various scientific and medical applications.
Latest Patents
Valenzuela holds a patent titled "Methods and Compositions for Targeted Genetic Modification Using Paired Guide RNAs." This patent represents a significant advancement in the techniques used for genetic engineering, allowing for more accurate and efficient modifications.
Career Highlights
David M Valenzuela is currently associated with Regeneron Pharmaceuticals, Inc., a leading biotechnology company known for its focus on developing medicines for serious diseases. His work at Regeneron has positioned him at the forefront of genetic research and innovation.
Collaborations
Due to space constraints, the details of his collaborations will not be included.
Conclusion
David M Valenzuela's contributions to genetic modification through his innovative patent and work at Regeneron Pharmaceuticals, Inc. highlight his role as a significant figure in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile